TRAD CHI MED (00570) Income Statement & Earnings

1.270
-0.025-1.93%

15min DelayMarket Closed Sep 11 16:00 CST

6.40BMarket Cap-5.50P/E (TTM)

TRAD CHI MED (00570) Income Statement

Cumulative·All

YOY

Hide blank lines

Currency: CNY

2026/H1

2025/FY

2025/H1

2024/FY

2024/H1

2023/FY

2023/H1

2022/FY

2022/H1

2021/FY

2021/H1

2020/FY

2020/H1

2019/FY

2019/H1

2018/FY

2018/H1

2017/FY

2017/H1

2016/FY

Total Revenue

-27.13%5.44B

-10.69%14.74B

-11.00%7.46B

-8.90%16.51B

-9.86%8.39B

+26.69%18.12B

+57.37%9.30B

-24.92%14.30B

-27.46%5.91B

+28.68%19.05B

+22.45%8.15B

+3.39%14.81B

-4.06%6.66B

+27.20%14.32B

+27.02%6.94B

+35.03%11.26B

+40.07%5.46B

+27.63%8.34B

+21.88%3.90B

+76.12%6.53B

Operating Revenue

-27.13%5.44B

-10.69%14.74B

-11.00%7.46B

-8.90%16.51B

-9.86%8.39B

+26.69%18.12B

+57.37%9.30B

-24.92%14.30B

-27.46%5.91B

+28.68%19.05B

+22.45%8.15B

+3.39%14.81B

-4.06%6.66B

+27.20%14.32B

+27.02%6.94B

+35.03%11.26B

+40.07%5.46B

+27.63%8.34B

+21.88%3.90B

+76.12%6.53B

Cost of Revenue

+25.36%-2.86B

+11.55%-7.65B

+11.46%-3.83B

+2.19%-8.65B

+4.86%-4.32B

-24.51%-8.85B

-53.56%-4.54B

+1.63%-7.11B

+5.94%-2.96B

-27.17%-7.22B

-19.26%-3.15B

+1.13%-5.68B

+4.05%-2.64B

-13.42%-5.75B

-8.66%-2.75B

-37.41%-5.07B

-46.34%-2.53B

-34.28%-3.69B

-26.64%-1.73B

-81.95%-2.75B

Cost of Goods Sold

+25.36%-2.86B

+11.55%-7.65B

+11.46%-3.83B

+2.19%-8.65B

+4.86%-4.32B

-24.51%-8.85B

-53.56%-4.54B

+1.63%-7.11B

+5.94%-2.96B

-27.17%-7.22B

-19.26%-3.15B

+1.13%-5.68B

+4.05%-2.64B

-13.42%-5.75B

-8.66%-2.75B

-37.41%-5.07B

-46.34%-2.53B

-34.28%-3.69B

-26.64%-1.73B

-81.95%-2.75B

Gross Profit

-28.99%2.58B

-9.74%7.09B

-10.51%3.63B

-15.29%7.86B

-14.64%4.06B

+28.84%9.27B

+61.19%4.76B

-39.15%7.20B

-41.00%2.95B

+29.62%11.83B

+24.54%5.00B

+6.42%9.13B

-4.07%4.02B

+38.46%8.58B

+42.87%4.19B

+33.15%6.19B

+35.07%2.93B

+22.81%4.65B

+18.33%2.17B

+72.11%3.79B

Operating Expense

+20.87%-2.77B

+5.36%-6.79B

+5.22%-3.50B

+11.82%-7.18B

+8.01%-3.69B

-31.94%-8.14B

-62.27%-4.01B

+33.40%-6.17B

+34.30%-2.47B

-34.31%-9.26B

-23.21%-3.76B

-9.89%-6.90B

-1.24%-3.05B

-48.56%-6.28B

-61.88%-3.02B

-41.98%-4.23B

-42.36%-1.86B

-19.75%-2.98B

-12.46%-1.31B

-50.55%-2.49B

Selling Expenses

+26.07%-1.89B

+8.57%-4.95B

+7.13%-2.56B

+15.37%-5.42B

+13.63%-2.75B

-39.08%-6.40B

-85.61%-3.19B

+39.28%-4.60B

+43.58%-1.72B

-35.71%-7.58B

-24.58%-3.04B

-9.35%-5.59B

+0.43%-2.44B

-49.51%-5.11B

-64.70%-2.45B

-40.21%-3.42B

-45.71%-1.49B

-23.81%-2.44B

-16.59%-1.02B

-64.63%-1.97B

Administrative Expenses

-10.30%-552.08M

-5.46%-1.12B

+2.27%-500.54M

-1.38%-1.06B

-10.20%-512.15M

-10.47%-1.04B

-15.72%-464.75M

+3.08%-944.40M

-5.77%-401.61M

-37.77%-974.45M

-13.79%-379.70M

-3.07%-707.28M

-10.10%-333.68M

-24.24%-686.19M

-37.03%-303.08M

-58.05%-552.29M

-33.78%-221.17M

-5.90%-349.45M

+11.74%-165.32M

-21.06%-329.99M

Research and Development Expenses

+26.79%-187.51M

+14.18%-511.47M

+4.40%-256.12M

+13.07%-596.01M

+14.57%-267.93M

-12.06%-685.63M

+1.23%-313.61M

+11.90%-611.83M

-7.75%-317.53M

-26.15%-694.44M

-20.13%-294.70M

-18.64%-550.47M

-17.38%-245.32M

-33.89%-464.00M

-40.19%-209.00M

-71.42%-346.54M

-22.61%-149.09M

-8.20%-202.16M

-21.56%-121.60M

-66.33%-186.83M

Impairment and Provision

+25.12%-139.19M

-99.49%-212.57M

-17.07%-185.88M

-1037.67%-106.55M

-232.37%-158.77M

+7.02%-9.37M

-29.33%-47.77M

+27.42%-10.07M

+20.19%-36.94M

+74.17%-13.88M

-39.65%-46.28M

-198.32%-53.73M

+36.19%-33.14M

-119.87%-18.01M

-1190.01%-51.94M

+613.15%90.65M

---4.03M

--12.71M

----

-Impairment Losses of Other Assets

+25.12%-139.19M

-99.49%-212.57M

-17.07%-185.88M

-1037.67%-106.55M

-232.37%-158.77M

+7.02%-9.37M

-29.33%-47.77M

+27.42%-10.07M

+20.19%-36.94M

+74.17%-13.88M

-39.65%-46.28M

-198.32%-53.73M

+36.19%-33.14M

-119.87%-18.01M

-1190.01%-51.94M

+613.15%90.65M

---4.03M

--12.71M

----

Special Items of Operating Income

-213.98%-537.97M

-65.79%-565.70M

-1255.45%-171.34M

-215.94%-341.22M

-78.55%14.83M

+712.16%294.30M

-24.19%69.13M

-80.79%36.24M

+18.56%91.19M

-28.22%188.63M

-47.42%76.91M

+61.93%262.77M

+74.22%146.27M

-13.61%162.28M

+26.19%83.96M

+69.32%187.83M

+158.07%66.53M

+49.20%110.94M

-11.79%25.78M

-47.21%74.35M

Operating Profit

-1934.13%-725.96M

-180.13%-268.90M

-109.28%-35.69M

-76.49%335.59M

-52.76%384.58M

+34.11%1.43B

+42.82%814.05M

-61.34%1.06B

-56.68%569.97M

+10.54%2.75B

+18.73%1.32B

+1.22%2.49B

-11.61%1.11B

+14.13%2.46B

+10.62%1.25B

+20.69%2.16B

+27.87%1.13B

+29.76%1.79B

+26.86%886.29M

+99.30%1.38B

Financing Cost

+28.16%-33.91M

+42.21%-99.13M

+43.99%-47.20M

+13.82%-171.54M

+20.07%-84.27M

+9.81%-199.05M

-6.97%-105.44M

+0.60%-220.70M

+10.34%-98.57M

+9.25%-222.03M

+2.63%-109.93M

+18.73%-244.67M

-1.25%-112.89M

-2.99%-301.05M

+10.28%-111.51M

-32.22%-292.30M

-45.87%-124.28M

-201.09%-221.07M

-149.40%-85.20M

---73.42M

Share of Profits of Associates

-21.28%-57.00K

+79.26%-197.00K

+94.62%-47.00K

+74.32%-950.00K

+51.34%-874.00K

-6.32%-3.70M

-9.51%-1.80M

+67.63%-3.48M

+79.00%-1.64M

+32.29%-10.75M

-60.66%-7.81M

-214.27%-15.87M

-194.01%-4.86M

+28.13%-5.05M

+72.95%-1.65M

-479.48%-7.03M

-229.74%-6.11M

+317.12%1.85M

-316.98%-1.85M

+127.12%444.00K

Pretax Profit

-816.25%-759.93M

-325.76%-368.23M

-127.70%-82.94M

-86.68%163.11M

-57.64%299.43M

+45.76%1.22B

+50.46%706.81M

-66.67%840.11M

-60.78%469.77M

+13.01%2.52B

+20.96%1.20B

+3.50%2.23B

-13.16%990.37M

+16.05%2.15B

+13.72%1.14B

+18.47%1.86B

+25.48%1.00B

+20.20%1.57B

+20.12%799.24M

+89.19%1.30B

Tax

-27.11%-74.77M

+36.87%-89.86M

+31.03%-58.82M

-182.98%-142.34M

+5.08%-85.29M

+243.97%171.54M

-86.30%-89.85M

+69.98%-119.14M

+74.78%-48.23M

-7.42%-396.86M

-19.40%-191.24M

+3.11%-369.45M

+13.90%-160.17M

-31.64%-381.32M

-10.45%-186.03M

-13.24%-289.67M

-23.41%-168.42M

-17.74%-255.80M

-13.47%-136.47M

-82.41%-217.26M

Net Profit

-488.81%-834.70M

-2305.43%-458.09M

-166.20%-141.76M

-98.51%20.77M

-65.29%214.14M

+93.64%1.40B

+46.36%616.96M

-66.05%720.97M

-58.13%421.54M

+14.12%2.12B

+21.26%1.01B

+4.93%1.86B

-13.02%830.20M

+13.16%1.77B

+14.38%954.44M

+19.49%1.57B

+25.90%834.45M

+20.70%1.31B

+21.59%662.77M

+68.70%1.09B

Profit from Continuing Operations

-488.81%-834.70M

-2305.43%-458.09M

-166.20%-141.76M

-98.51%20.77M

-65.29%214.14M

+93.64%1.40B

+46.36%616.96M

-66.05%720.97M

-58.13%421.54M

+14.12%2.12B

+21.26%1.01B

+4.93%1.86B

-13.02%830.20M

+13.16%1.77B

+14.38%954.44M

+19.49%1.57B

+25.90%834.45M

+20.70%1.31B

+21.59%662.77M

+90.60%1.09B

Minority Interests

-72.56%-58.40M

-248.45%-116.02M

-1169.60%-33.84M

-130.03%-33.30M

-91.72%3.16M

+354.75%110.87M

+380.91%38.22M

-122.84%-43.52M

-89.66%7.95M

-3.46%190.57M

-21.72%76.85M

+6.59%197.39M

+3.00%98.18M

+44.66%185.18M

+28.56%95.32M

-9.21%128.01M

+15.58%74.14M

+17.88%141.00M

+18.13%64.15M

+548.20%119.61M

Net Income to Parent Company

-619.34%-776.30M

-732.68%-342.07M

-151.15%-107.92M

-95.79%54.07M

-63.55%210.98M

+68.11%1.29B

+39.93%578.74M

-60.45%764.49M

-55.52%413.59M

+16.21%1.93B

+27.02%929.83M

+4.73%1.66B

-14.79%732.02M

+10.36%1.59B

+13.00%859.12M

+22.95%1.44B

+27.01%760.31M

+21.05%1.17B

+21.97%598.62M

+54.56%966.93M

Net Income to Common Stockholders

-619.34%-776.30M

-732.68%-342.07M

-151.15%-107.92M

-95.79%54.07M

-63.55%210.98M

+68.11%1.29B

+39.93%578.74M

-60.45%764.49M

-55.52%413.59M

+16.21%1.93B

+27.02%929.83M

+4.73%1.66B

-14.79%732.02M

+10.36%1.59B

+13.00%859.12M

+22.95%1.44B

+27.01%760.31M

+21.05%1.17B

+21.97%598.62M

+54.56%966.93M

Basic EPS

-620.56%-0.15

-734.58%-0.07

-151.07%-0.02

-95.81%0.01

-63.53%0.04

+68.12%0.26

+39.95%0.11

-60.45%0.15

-55.53%0.08

+16.20%0.38

+26.96%0.18

+4.72%0.33

-14.77%0.15

+5.70%0.32

+3.33%0.17

+12.99%0.30

+22.21%0.17

+21.54%0.26

+23.04%0.14

+28.05%0.22

Diluted EPS

-620.56%-0.15

-734.58%-0.07

-151.07%-0.02

-95.81%0.01

-63.53%0.04

+68.12%0.26

+39.95%0.11

-60.45%0.15

-55.53%0.08

+16.20%0.38

+26.96%0.18

--0.33

--0.15

----

--0.26

+23.04%0.14

----

Deadline

Jun 30, 2026

Dec 31, 2025

Jun 30, 2025

Dec 31, 2024

Jun 30, 2024

Dec 31, 2023

Jun 30, 2023

Dec 31, 2022

Jun 30, 2022

Dec 31, 2021

Jun 30, 2021

Dec 31, 2020

Jun 30, 2020

Dec 31, 2019

Jun 30, 2019

Dec 31, 2018

Jun 30, 2018

Dec 31, 2017

Jun 30, 2017

Dec 31, 2016

Accounting Standard

HKAS

Audit Opinions

Unqualified opinion

	2026/H1	2025/FY	2025/H1	2024/FY	2024/H1	2023/FY	2023/H1	2022/FY	2022/H1	2021/FY	2021/H1	2020/FY	2020/H1	2019/FY	2019/H1	2018/FY	2018/H1	2017/FY	2017/H1	2016/FY

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"